Nasus Pharma Ltd (NSRX) KPIs and segments

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30

$2.87+0.05 (+1.77%)

Close on Nov 13, 2026Market cap $25.87MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Nasus Pharma's business

Coming soon

This tab will track the numbers specific to Nasus Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?